Diagnosis: High-risk Gestational Trophoblastic Neoplasia (GTN) -- Pulmonary metastasis (cannon-ball lesions on CXR) after molar evacuation = choriocarcinoma or high-risk GTN.
WHO/FIGO risk scoring: A prognostic score $\geq 7$ = high-risk GTN. Presence of pulmonary metastasis increases the score significantly.
Treatment:
Low-risk GTN (score < 7, no metastasis): Single-agent chemotherapy -- methotrexate or actinomycin D.
High-risk GTN (score $\geq 7$, metastases): Multi-agent EMACO regimen.
EMACO regimen breakdown:
Day 1 and Day 2:
- Etoposide 100 mg/m$^2$ IV
- Actinomycin D 0.5 mg IV bolus
- Methotrexate 100 mg/m$^2$ IV push + 200 mg/m$^2$ IV over 12 hr
Day 2: Folinic acid rescue
Day 8:
- Cyclophosphamide 600 mg/m$^2$ IV
- Vincristine (Oncovin) 1 mg/m$^2$ IV (max 2 mg)
Cure rate with EMACO in high-risk GTN: $\sim$75--90%.
Hysterectomy is reserved for drug-resistant cases as an adjunct.
\[\boxed{\text{EMACO regimen}}\]